Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Account Payables (2023 - 2025)

CervoMed's Change in Account Payables history spans 8 years, with the latest figure at -$434813.0 for Q3 2025.

  • For Q3 2025, Change in Account Payables fell 221.94% year-over-year to -$434813.0; the TTM value through Sep 2025 reached $266784.0, down 55.72%, while the annual FY2024 figure was $848969.0, 50.22% up from the prior year.
  • Change in Account Payables for Q3 2025 was -$434813.0 at CervoMed, down from -$76566.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $429005.0 in Q4 2024 and bottomed at -$434813.0 in Q3 2025.
  • The 3-year median for Change in Account Payables is $240257.0 (2023), against an average of $113810.6.
  • The largest annual shift saw Change in Account Payables skyrocketed 453.47% in 2024 before it tumbled 221.94% in 2025.
  • A 3-year view of Change in Account Payables shows it stood at $182494.0 in 2023, then surged by 135.08% to $429005.0 in 2024, then crashed by 201.35% to -$434813.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Change in Account Payables are -$434813.0 (Q3 2025), -$76566.0 (Q2 2025), and $349158.0 (Q1 2025).